Gold vs US Dollar

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
NeuroBo Pharmaceuticals Inc (NRBO)
NeuroBo Pharmaceuticals Inc (NRBO) Financials

NRBO NeuroBo Pharmaceuticals Inc

4.17

0.06 (1.46%)

Last Updated: 20:46:28

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-102.222	-152.681	-122.12	-124.77	-233.354	-110.088	-55.498	-44.287
Return on Equity (%)	-362.385	-271.965	-403.534	-212.419	-304.468	-140.22	-76.854	-64.889
Return on Invested Capital (%)	-397.888	-199.302	-223.776	-201.177	-304.858	-140.349	-108.003	-82.709
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	2.226	0.371	0.545	0.788	0.366	0.547	0.855	0.43
Earnings Per Share	-1.613	-3.143	-1.657	-1.367	-1.509	-0.573	-0.549	-0.321
Cash Per Share	2.593	1.737	1.329	0.892	0.513	0.615	1.312	0.578
Working Capital Per Share	2.225	1.187	0.544	0.772	0.355	0.541	0.855	0.426
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	-1.573	-3.143	-1.657	-1.367	-1.509	-0.573	-0.549	-0.321
EBITDA Per Share	-1.573	-3.143	-1.657	-1.367	-1.509	-0.573	-0.549	-0.321
Free Cash Flow Per Share	-1.613	-3.143	-1.657	-1.354	-1.511	-0.575	-0.55	-0.32

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	6.005	2.975	1.652	6.781	2.891	7.688	2.846	3.777
Quick Ratio	5.832	2.891	1.59	6.687	2.73	7.597	2.831	3.764
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	9.27M	10.63M	14.27M	15.59M	19.67M	26.66M	25.44M	N/A

Key Stats and Ratios

Year End 31 December 2023	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	26.66M	26.66M	889k	25.44M	N/A	38.43M	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	8.866	N/A	N/A	N/A	2.867	N/A	N/A	N/A
Quick Ratio	7.725	N/A	N/A	N/A	2.806	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	20.33M
Price to Earnings Ratio	-1.63
Price to Sales Ratio	0
Price to Cash Ratio	0.91
Price to Book Ratio	1.22
Dividend Yield	-

Share Statistics

Shares Outstanding	4.85M
Average Volume (1 week)	17.84k
Average Volume (1 Month)	23.51k
52 Week Change	-11.65%
52 Week High	6.7499
52 Week Low	2.8888

More Ratios Coming Soon!

NeuroBo Pharmaceuticals

Societe Generale Effekten

DJ US Biotechnology Tota...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions